309 related articles for article (PubMed ID: 34595449)
1. Cold Agglutinin Disease.
Gabbard AP; Booth GS
Clin Hematol Int; 2020 Sep; 2(3):95-100. PubMed ID: 34595449
[TBL] [Abstract][Full Text] [Related]
2. Three different pathways of IgM-antibody-dependent hemolysis are mainly regulated by complement.
Bartolmäs T; Pruß A; Mayer B
Front Immunol; 2023; 14():1114509. PubMed ID: 36817469
[TBL] [Abstract][Full Text] [Related]
3. [Progress in diagnosis and treatment of autoimmune hemolytic anemia].
Kamesaki T
Rinsho Ketsueki; 2019; 60(9):1100-1107. PubMed ID: 31597833
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Hemolytic Anemia in the Pediatric Setting.
Voulgaridou A; Kalfa TA
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33435309
[TBL] [Abstract][Full Text] [Related]
5. Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients.
Wang Z; Bo L; Xu Y; Liu H; Zhao Y
Int J Lab Hematol; 2021 Oct; 43(5):1154-1158. PubMed ID: 33459487
[TBL] [Abstract][Full Text] [Related]
6. [A new approach for diagnosis of autoimmune hemolytic anemia].
Kajii E; Omi T; Miura Y; Ikemoto S
Rinsho Ketsueki; 1994 Apr; 35(4):336-40. PubMed ID: 8028177
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune hemolytic anemia.
Hill A; Hill QA
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):382-389. PubMed ID: 30504336
[TBL] [Abstract][Full Text] [Related]
8. [Cold agglutinin disease - no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic Anemia in the Setting of Atypical Pneumonia: A Case of Cold Agglutinin Disease.
Jalal Eldin A; Thomas R; Gibson G; Abongwa D; Hassan I; Tabot Tabot MK; Singh G; Sarma R
Cureus; 2023 May; 15(5):e39734. PubMed ID: 37398820
[TBL] [Abstract][Full Text] [Related]
10. Immune Hemolysis: Diagnosis and Treatment Recommendations.
Barcellini W
Semin Hematol; 2015 Oct; 52(4):304-12. PubMed ID: 26404442
[TBL] [Abstract][Full Text] [Related]
11. Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.
Arndt PA; Leger RM; Garratty G
Transfusion; 2009 Feb; 49(2):235-42. PubMed ID: 18980619
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies for treatment of cold agglutinin disease.
Gelbenegger G; Berentsen S; Jilma B
Expert Opin Biol Ther; 2023 May; 23(5):395-406. PubMed ID: 37128907
[TBL] [Abstract][Full Text] [Related]
13. IgM Warm Autoantibodies Causing Autoimmune Hemolytic Anemia in a Pediatric Patient.
Fortes P; Baez J; McGonigle AM; Ziman A; Federman N; Ward DC
Lab Med; 2022 Jul; 53(4):e83-e86. PubMed ID: 34865065
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune hemolytic anemias].
Subran B; Montagner C; Lidove O
Rev Prat; 2020 Jan; 70(1):79-87. PubMed ID: 32877037
[TBL] [Abstract][Full Text] [Related]
15. Complement-directed therapy for cold agglutinin disease: sutimlimab.
Broome CM
Expert Rev Hematol; 2023; 16(7):479-494. PubMed ID: 37256550
[TBL] [Abstract][Full Text] [Related]
16. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.
Berentsen S
Front Immunol; 2020; 11():590. PubMed ID: 32318071
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hemolytic anemia.
Čermák J; Písačka M
Vnitr Lek; 2018; 64(5):514-519. PubMed ID: 30193520
[TBL] [Abstract][Full Text] [Related]
18. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.
Berentsen S
Semin Hematol; 2018 Jul; 55(3):141-149. PubMed ID: 30032751
[TBL] [Abstract][Full Text] [Related]
19. In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
Juskewitch JE; Murray JD; Norgan AP; Moldenhauer SK; Tauscher CD; Jacob EK; Murray DL
Transfusion; 2021 Apr; 61(4):1302-1311. PubMed ID: 33502021
[TBL] [Abstract][Full Text] [Related]
20. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
Berentsen S; Barcellini W; D'Sa S; Jilma B
Immunotherapy; 2022 Oct; 14(15):1191-1204. PubMed ID: 35946351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
